土耳其对老年人脆弱指数的调整:一项方法学研究
Fatma Zehra Genç1, Arzu Uslu2, Naile Bilgili3
1Department of Public Health Nursing, Scientific Publications Coordination Office, Necmettin Erbakan University, Konya, Turkey.
Journal of nursing measurement
|April 3, 2024
概括
这项研究将老年人脆弱指数 (FIFE) 改编为土耳其语. 经过验证的七项FIFE是衡量土耳其老年人脆弱性的可靠工具.
科学领域:
- 老年学是一门学科.
- 老年医学 老年医学
- 心理测量 心理测量 心理测量
背景情况:
- 脆弱性是衰老的一个重要问题,需要早期发现和干预.
- 有效的测量工具对于识别和管理老年人群的脆弱性至关重要.
- 老年人脆弱指数 (FIFE) 是评估脆弱性的关键工具.
研究的目的:
- 适应和验证老年人脆弱指数 (FIFE) 用于土耳其语.
- 为了确定FIFE的土耳其版本的心理测量特性.
- 为评估土耳其老年人的脆弱性提供可靠和有效的工具.
主要方法:
- 一项涉及300名老年人的横截面研究.
- 拉什分析被用来评估构造的有效性.
- 克伦巴赫的alpha (KR-20) 和专家意见被用于可靠性和内容有效性评估.
主要成果:
- 土耳其FIFE表现出极好的内部一致性 (可靠性系数= .98).
- 较高的项目分离 (7.62) 和项目可靠性 (.98) 表示强大的测量特性.
- 强含量有效性 (.85) 和测试重试可靠性 (.92) 得到证实.
结论:
- 七项,单一因素的FIFE的土耳其版本是一个有效和可靠的工具.
- 这种经过验证的工具可以有效地用于测量居住在土耳其的老年人的脆弱性.
- 使用土耳其FIFE早期发现脆弱性可以促进及时干预并改善老年护理.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


